Clinical Trial Update: Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating low-dose ondansetron as adjunctive therapy for adults with obsessive-compulsive disorder was terminated; the update does not provide ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Zofran (Ondansetron)

Snippet

Sponsor: Transcept Pharmaceuticals | Conditions: Obsessive-compulsive Disorder | Phase 2 | Status: TERMINATED